Coastal Bridge Advisors LLC Makes New $1.14 Million Investment in CME Group Inc. $CME

Coastal Bridge Advisors LLC purchased a new stake in CME Group Inc. (NASDAQ:CME) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 5,153 shares of the financial services provider’s stock, valued at approximately $1,138,000.

Several other large investors have also modified their holdings of the business. Empowered Funds LLC raised its position in shares of CME Group by 11.5% during the 1st quarter. Empowered Funds LLC now owns 10,027 shares of the financial services provider’s stock worth $2,660,000 after purchasing an additional 1,037 shares during the last quarter. Marshall Wace LLP lifted its stake in CME Group by 103.1% in the 2nd quarter. Marshall Wace LLP now owns 3,692 shares of the financial services provider’s stock valued at $1,018,000 after buying an additional 121,707 shares in the last quarter. Federated Hermes Inc. grew its holdings in CME Group by 1,325.2% during the 2nd quarter. Federated Hermes Inc. now owns 23,572 shares of the financial services provider’s stock valued at $6,497,000 after buying an additional 21,918 shares during the last quarter. Nebula Research & Development LLC acquired a new stake in CME Group during the 2nd quarter valued at $992,000. Finally, The Manufacturers Life Insurance Company increased its position in CME Group by 2.6% during the second quarter. The Manufacturers Life Insurance Company now owns 287,876 shares of the financial services provider’s stock worth $79,344,000 after buying an additional 7,397 shares in the last quarter. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research firms have recently weighed in on CME. TD Cowen cut their price target on CME Group from $323.00 to $273.00 and set a “buy” rating for the company in a report on Monday, June 22nd. JPMorgan Chase & Co. increased their price objective on CME Group from $249.00 to $250.00 and gave the company an “underweight” rating in a research note on Thursday, July 23rd. Weiss Ratings cut CME Group from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Tuesday, August 11th. Rothschild & Co Redburn raised shares of CME Group from a “neutral” rating to a “buy” rating and boosted their target price for the company from $316.00 to $323.00 in a research note on Thursday, June 11th. Finally, Morgan Stanley upped their target price on shares of CME Group from $324.00 to $330.00 and gave the company an “overweight” rating in a report on Thursday, July 23rd. Nine equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have given a Sell rating to the company’s stock. According to MarketBeat.com, CME Group has an average rating of “Hold” and an average price target of $288.56.

Insider Transactions at CME Group

In other CME Group news, Director William R. Shepard purchased 325 shares of the firm’s stock in a transaction on Thursday, June 25th. The shares were purchased at an average cost of $230.57 per share, with a total value of $74,935.25. Following the purchase, the director owned 260,442 shares in the company, valued at approximately $60,050,111.94. This represents a 0.12% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Insiders own 0.30% of the company’s stock.

CME Group Trading Down 0.0%

Shares of CME opened at $280.94 on Friday. The stock has a fifty day moving average of $253.01 and a two-hundred day moving average of $279.09. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The company has a market capitalization of $101.02 billion, a PE ratio of 23.83, a price-to-earnings-growth ratio of 3.34 and a beta of 0.23. CME Group Inc. has a fifty-two week low of $218.31 and a fifty-two week high of $329.16.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.91 by $0.08. The business had revenue of $1.71 billion for the quarter, compared to analysts’ expectations of $1.68 billion. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The business’s revenue was up .8% on a year-over-year basis. During the same quarter last year, the firm earned $2.96 earnings per share. As a group, analysts forecast that CME Group Inc. will post 12.27 EPS for the current year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 25th. Investors of record on Wednesday, September 9th will be given a dividend of $1.30 per share. The ex-dividend date is Wednesday, September 9th. This represents a $5.20 annualized dividend and a yield of 1.9%. CME Group’s dividend payout ratio is 44.11%.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.